VDACs: Transmembrane Proteins Regulating Ion Transport, Neurotransmitter Release and Blood Pressure

Target Name: Voltage-dependent anion channels (Porins)

NCBI ID: P45752

Voltage-dependent anion channels (Porins)

Other Name(s): None

VDACs: Transmembrane Proteins Regulating Ion Transport, Neurotransmitter Release and Blood Pressure

Voltage-dependent anion channels (VDACs), also known as porins, are a family of transmembrane proteins that play a crucial role in various physiological processes in the body, including ion transport, neurotransmitter release, and cell signaling. They are found in many different cell types and are involved in the regulation of a wide range of physiological processes, including muscle contractions, neural signaling, and blood pressure.

VDACs are characterized by their ability to transmit voltage-dependent anions through their channels. These anions can include a variety of different molecules, such as ions, molecules such as neurotransmitters, or even small molecules. The strength and direction of the ion flow is regulated by the voltage applied to the channel, which allows for a precise control over the amount of ion transport that occurs.

VDACs are involved in many different biological processes that are critical for the proper functioning of the body. For example, they are involved in the regulation of muscle contractions, which are essential for movement and maintaining posture. VDACs are also involved in the regulation of neurotransmitter release, which is critical for the transmission of signals within the nervous system. They are also involved in the regulation of blood pressure, which is critical for maintaining proper circulation and oxygenation of the body's tissues.

In addition to their role in physiological processes, VDACs are also potential drug targets or biomarkers. Many drugs that are used to treat a variety of conditions, such as heart disease, neurodegenerative diseases, and hypertension, work by modulating the activity of VDACs. For example, some drugs used to treat hypertension work by blocking the channels and reducing the amount of ion flow that enters the channels, which can cause blood pressure to drop.

VDACs are also a potential biomarker for certain diseases, as their activity can be affected by a variety of different factors, such as neurotransmitters, toxins, or certain medications. For this reason, they are often used as a target for researchers to study the underlying mechanisms of certain diseases.

In conclusion, VDACs are a family of transmembrane proteins that play a crucial role in various physiological processes in the body. They are involved in the regulation of ion transport, neurotransmitter release, and blood pressure, among many other things. They are also drug potential targets or biomarkers, and their activity can be affected by a variety of different factors. Further research is needed to fully understand the role of VDACs in the regulation of physiological processes and their potential as drug targets or biomarkers.

Protein Name: Voltage-dependent Anion Channels (Porins) (nonspecified Subtype)

The "Voltage-dependent anion channels (Porins) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Voltage-dependent anion channels (Porins) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets